Five more countries to join EMA-FDA mutual recognition
The US FDA has announced that it will confirm the capability of five more countries to carry out good manufacturing practice (GMP)...
List view / Grid view
The US FDA has announced that it will confirm the capability of five more countries to carry out good manufacturing practice (GMP)...
CPhI & P-MEC India opens as report ranks India the world’s fastest improving pharma market and first for ‘growth potential’ for 2019...
Research into detecting tau proteins in the brains of Alzheimer's patients has shown that a specific tracer could detect and measure the protein levels...
A phase III clinical trial showed that neoadjuvant chemotherapy and trastuzumab reduced the risk of recurrence of HER2-positive early-stage breast cancer...
A team of Iranian researchers have determined that trastuzumab taken with a heart drug leads to less heart damage in breast cancer patients...
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
The development of a drug that could be used to save women from postpartum hemorrhaging, could save many thousands of women each year...
Researchers have developed a method of using less contrast medium to still obtain high quality images in magnetic resonance imaging (MRI)...
A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two years after the start...
A tiny microneedle patch could be the future of delivering therapeutic cell related drugs to the heart of patients after a heart attack...
Metrohm USA is proud to continue its productive collaboration with USP on a global initiative to modernise monographs that have traditionally featured wet chemistry methods...
A nanoscale blood test could be used to gain more information from the blood of patients in order to help the identification of cancer in its early stages...
A gene therapy called AAV2-GAD has been associated with improved motor function, leading to researchers looking at its use in an upcoming Phase III trial...
Results of a clinical trial has led to the FDA approval of a monoclonal antibody drug called lanadelumab, to treat hereditary angioedema attacks...
The use of pRF also could improve outcomes for patients set to receive corticosteroid injections, and was found to be minimally invasive with good results...